News Featured May 27, 2026 Arima Genomics Announces Presentation of New Data at ASCO 2026 Supporting Clinical Utility of Hi-C Sequencing in Non-Small Cell Lung Cancer May 27, 2026 May 27, 2026 April 15, 2026 Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors April 15, 2026 April 15, 2026 February 26, 2026 Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma February 26, 2026 February 26, 2026 January 8, 2026 Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care January 8, 2026 January 8, 2026 December 4, 2025 Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma December 4, 2025 December 4, 2025 November 13, 2025 Arima Genomics Announces Data Presentation at the Association of Molecular Pathology 2025 November 13, 2025 November 13, 2025 November 6, 2025 Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year” November 6, 2025 November 6, 2025 October 15, 2025 Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases October 15, 2025 October 15, 2025 September 3, 2025 Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas September 3, 2025 September 3, 2025 June 17, 2025 Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing June 17, 2025 June 17, 2025 April 10, 2025 New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests April 10, 2025 April 10, 2025
